Balancing safety against need

When Pfizer followed Merck & co in withdrawing one of their COX-2 inhibitors from the market owing to increased risks of cardiovascular complications, it provided a timely reminder that medicines are not without their risks. [more]

Brainwaves in drug delivery

Number 5

1 March 2005 0

Delivering drugs through the blood-brain barrier has always confounded scientists, but new developments in both non-invasive targeted brain delivery and brain-implanted drug formulations may provide a way forward. Download full article

1 2
UA-77507851-1